1. Biochim Biophys Acta Mol Basis Dis. 2022 Oct 1;1868(10):166467. doi: 
10.1016/j.bbadis.2022.166467. Epub 2022 Jun 15.

Disease causing mutation (P178L) in mitochondrial transcription factor A results 
in impaired mitochondrial transcription initiation.

Mehmedović M(1), Martucci M(2), Spåhr H(3), Ishak L(1), Mishra A(1), 
Sanchez-Sandoval ME(1), Pardo-Hernández C(1), Peter B(1), van den Wildenberg 
SM(4), Falkenberg M(5), Farge G(6).

Author information:
(1)Department of Medical Biochemistry and Cell Biology, University of 
Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden.
(2)Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, 
F-63000 Clermont-Ferrand, France.
(3)Department of Mitochondrial Biology, Max Planck Institute for Biology of 
Ageing, 50931 Cologne, Germany; Department of Medical Biochemistry and 
Biophysics, Karolinska Institutet, Stockholm 17177, Sweden; Max Planck Institute 
for Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 
Stockholm 17177, Sweden.
(4)Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, 
F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CNRS, IRD, 
Université Jean Monnet Saint Etienne, LMV, F-63000 Clermont-Ferrand, France.
(5)Department of Medical Biochemistry and Cell Biology, University of 
Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden. Electronic address: 
maria.falkenberg@medkem.gu.se.
(6)Université Clermont Auvergne, CNRS, Laboratoire de Physique de Clermont, 
F-63000 Clermont-Ferrand, France. Electronic address: geraldine.farge@uca.fr.

Mitochondrial transcription factor A (TFAM) is essential for the maintenance, 
expression, and packaging of mitochondrial DNA (mtDNA). Recently, a pathogenic 
homozygous variant in TFAM (P178L) has been associated with a severe mtDNA 
depletion syndrome leading to neonatal liver failure and early death. We have 
performed a biochemical characterization of the TFAM variant P178L in order to 
understand the molecular basis for the pathogenicity of this mutation. We 
observe no effects on DNA binding, and compaction of DNA is only mildly affected 
by the P178L amino acid change. Instead, the mutation severely impairs mtDNA 
transcription initiation at the mitochondrial heavy and light strand promoters. 
Molecular modeling suggests that the P178L mutation affects promoter sequence 
recognition and the interaction between TFAM and the tether helix of POLRMT, 
thus explaining transcription initiation deficiency.

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

DOI: 10.1016/j.bbadis.2022.166467
PMID: 35716868 [Indexed for MEDLINE]